Aperio Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $984K | Buy |
23,375
+6,808
| +41% | +$287K | ﹤0.01% | 1596 |
|
|
2020
Q3 | $758K | Buy |
16,567
+4,782
| +41% | +$219K | ﹤0.01% | 1586 |
|
|
2020
Q2 | $592K | Buy |
11,785
+3,364
| +40% | +$169K | ﹤0.01% | 1692 |
|
|
2020
Q1 | $433K | Buy |
8,421
+821
| +11% | +$42.2K | ﹤0.01% | 1725 |
|
|
2019
Q4 | $470K | Sell |
7,600
-325
| -4% | -$20.1K | ﹤0.01% | 1834 |
|
|
2019
Q3 | $476K | Sell |
7,925
-111
| -1% | -$6.67K | ﹤0.01% | 1781 |
|
|
2019
Q2 | $678K | Buy |
8,036
+406
| +5% | +$34.3K | ﹤0.01% | 1614 |
|
|
2019
Q1 | $729K | Sell |
7,630
-23
| -0.3% | -$2.2K | ﹤0.01% | 1532 |
|
|
2018
Q4 | $542K | Buy |
7,653
+359
| +5% | +$25.4K | ﹤0.01% | 1631 |
|
|
2018
Q3 | $623K | Sell |
7,294
-83
| -1% | -$7.09K | ﹤0.01% | 1655 |
|
|
2018
Q2 | $855K | Buy |
7,377
+89
| +1% | +$10.3K | ﹤0.01% | 1482 |
|
|
2018
Q1 | $590K | Buy |
7,288
+899
| +14% | +$72.8K | ﹤0.01% | 1611 |
|
|
2017
Q4 | $375K | Buy |
6,389
+302
| +5% | +$17.7K | ﹤0.01% | 1841 |
|
|
2017
Q3 | $285K | Buy |
6,087
+356
| +6% | +$16.7K | ﹤0.01% | 1946 |
|
|
2017
Q2 | $206K | Buy |
+5,731
| New | +$206K | ﹤0.01% | 2084 |
|